Jay Edelberg

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

New England Journal of Medicine · 2018 · 2,762 citations

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet · 2020 · 1,067 citations